JP2022023136A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022023136A5 JP2022023136A5 JP2021169476A JP2021169476A JP2022023136A5 JP 2022023136 A5 JP2022023136 A5 JP 2022023136A5 JP 2021169476 A JP2021169476 A JP 2021169476A JP 2021169476 A JP2021169476 A JP 2021169476A JP 2022023136 A5 JP2022023136 A5 JP 2022023136A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell population
- baff
- vivo cultured
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024063798A JP2024091728A (ja) | 2016-03-14 | 2024-04-11 | Ｔ細胞の拡張及び活性化の方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307989P | 2016-03-14 | 2016-03-14 | |
| US62/307,989 | 2016-03-14 | ||
| PCT/US2017/022260 WO2017160806A1 (en) | 2016-03-14 | 2017-03-14 | Methods of t cell expansion and activation |
| JP2018548805A JP6963560B2 (ja) | 2016-03-14 | 2017-03-14 | Ｔ細胞の拡張及び活性化の方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548805A Division JP6963560B2 (ja) | 2016-03-14 | 2017-03-14 | Ｔ細胞の拡張及び活性化の方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024063798A Division JP2024091728A (ja) | 2016-03-14 | 2024-04-11 | Ｔ細胞の拡張及び活性化の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022023136A JP2022023136A (ja) | 2022-02-07 |
| JP2022023136A5 true JP2022023136A5 (https=) | 2022-05-02 |
Family
ID=58461445
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548805A Active JP6963560B2 (ja) | 2016-03-14 | 2017-03-14 | Ｔ細胞の拡張及び活性化の方法 |
| JP2021169476A Pending JP2022023136A (ja) | 2016-03-14 | 2021-10-15 | Ｔ細胞の拡張及び活性化の方法 |
| JP2024063798A Pending JP2024091728A (ja) | 2016-03-14 | 2024-04-11 | Ｔ細胞の拡張及び活性化の方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548805A Active JP6963560B2 (ja) | 2016-03-14 | 2017-03-14 | Ｔ細胞の拡張及び活性化の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024063798A Pending JP2024091728A (ja) | 2016-03-14 | 2024-04-11 | Ｔ細胞の拡張及び活性化の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US10563172B2 (https=) |
| EP (1) | EP3430130B1 (https=) |
| JP (3) | JP6963560B2 (https=) |
| WO (1) | WO2017160806A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10563172B2 (en) * | 2016-03-14 | 2020-02-18 | Wisconsin Alumni Research Foundation | Methods of T cell expansion and activation |
| EP4501408A3 (en) * | 2017-11-17 | 2025-04-09 | Iovance Biotherapeutics, Inc. | Til expansion from fine needle aspirates and small biopsies |
| WO2025212837A1 (en) * | 2024-04-04 | 2025-10-09 | The Regents Of The University Of Michigan | Enhanced anti-cancer t-cell therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003534283A (ja) | 2000-05-25 | 2003-11-18 | エクサイト セラピーズ， インコーポレイテッド | 天然で誘導されたかまたは人工的に誘導された免疫抑制後にｔ細胞免疫サーベイランスを回復もしくは増強するための方法 |
| WO2004094620A2 (en) * | 2003-03-28 | 2004-11-04 | Biogen Idec Ma Inc. | Truncated baff receptors |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CA2920377A1 (en) | 2013-08-05 | 2015-02-12 | Cambridge Enterprise Limited | Inhibition of cxcr4 signaling in cancer immunotherapy |
| US11028143B2 (en) * | 2014-01-21 | 2021-06-08 | Novartis Ag | Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules |
| US10563172B2 (en) * | 2016-03-14 | 2020-02-18 | Wisconsin Alumni Research Foundation | Methods of T cell expansion and activation |
-
2017
- 2017-03-14 US US15/458,339 patent/US10563172B2/en active Active
- 2017-03-14 EP EP17714950.7A patent/EP3430130B1/en active Active
- 2017-03-14 WO PCT/US2017/022260 patent/WO2017160806A1/en not_active Ceased
- 2017-03-14 JP JP2018548805A patent/JP6963560B2/ja active Active
-
2020
- 2020-01-07 US US16/736,389 patent/US12037606B2/en active Active
-
2021
- 2021-10-15 JP JP2021169476A patent/JP2022023136A/ja active Pending
-
2024
- 2024-04-11 JP JP2024063798A patent/JP2024091728A/ja active Pending
- 2024-06-26 US US18/754,949 patent/US20240398695A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cerwenka et al. | Natural killer cell memory in infection, inflammation and cancer | |
| Klingemann | The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer | |
| Song et al. | IL‐12/IL‐18‐preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation | |
| Jiang et al. | Balancing act: the complex role of NK cells in immune regulation | |
| Lim et al. | GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo | |
| JP6899333B2 (ja) | 汎用キラーｔ細胞 | |
| US12060577B2 (en) | Compositions for expanding natural killer cells | |
| CN109069539A (zh) | 用于癌症治疗的联合免疫疗法和细胞因子控制疗法 | |
| JP2021525518A (ja) | 細胞をゲノム編集及び活性化するための方法 | |
| JP2022023136A5 (https=) | ||
| JP2016539929A5 (https=) | ||
| RU2015153245A (ru) | Способы конструирования аллогенных и высокоактивных т-клеток для иммунотерапии | |
| US12427181B2 (en) | T-cell therapy method | |
| Giang et al. | Nanoparticles engineered as artificial antigen-presenting cells induce human CD4+ and CD8+ Tregs that are functional in humanized mice | |
| Xu et al. | Cellular immunotherapy for hematological malignancy: recent progress and future perspectives | |
| CN111902533A (zh) | 产生自然杀伤细胞的方法 | |
| CN104789595A (zh) | 嵌合抗原受体双阴性t细胞的构建方法 | |
| Jin et al. | The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia | |
| WO2012146702A1 (en) | Methods for preparing accessory cells and uses thereof for preparing activated nk cells | |
| CN105886469B (zh) | Cik细胞及其培养方法和应用 | |
| Dandia et al. | Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy | |
| Oyer et al. | PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival | |
| Chen et al. | Sequential treatment with aT19 cells generates memory CAR-T cells and prolongs the lifespan of Raji-B-NDG mice | |
| Gress et al. | Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of Relapse after Transplantation | |
| JP2019508056A5 (https=) |